EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Functional Roles of the Complement Immune System in Cardiac Inflammation and Hypertrophy

Kathryn D Hok iD, Haydn E Rich, Anthony Shadid iD, Lavanya Gunamalai, Tingting Weng-Mills iD, Rajarajan A Thandavarayan iD, Nirmal K Banda, Marie-Francoise Doursout, Marcos I Restrepo iD, Pooja Shivshankar

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26209931 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kathryn D Hok und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Metabolic and Degenerative Diseases, The Brown Foundation Institute of Molecular Medicine for Prevention of Human Diseases, UTHealth-McGov…. Hauptthemen laut MEDLINE: Cardiomegaly, Complement System Proteins, Inflammation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 251 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac inflammation and hypertrophy develop as a pathologic response to an array of insults, such as myocardial infarctions, chronic systemic hypertension, and valvular defects. Due to the high prevalence of such conditions, there is an increasing need to prevent and halt cardiac hypertrophy. Because cardiac damage and subsequent remodeling can lead to arrhythmias, heart failure, and even sudden cardiac death, inhibition of cardiac hypertrophy is key to reducing cardiovascular-related mortality. The immune system is the driving force behind inflammatory reactions. All three pathways of complement system activation—classical, lectin, and alternative—are implicated in developing cardiac damage, inflammation, and hypertrophy due to infectious and non-infectious causes, autoimmune diseases, genetic polymorphisms, and forms of complement dysregulation. Of interest in this review is the role of the complement system, a collection of soluble and membrane-bound proteins that mediate inflammatory processes through interactions with signaling molecules and immune cells. This review comprehensively discusses the roles of these complement pathways in contagious, chronic inflammatory, genetic, and metabolic diseases. An overview of the completed and terminated clinical trials aimed at preventing cardiovascular mortality by targeting various aspects of the complement system and inflammatory reaction is included. Most current treatments for cardiac inflammation and remodeling primarily target the renin–angiotensin–aldosterone system (RAAS), which prevents further remodeling by reducing myocardial workload. However, moving forward, there may be a place for emerging anti-complement therapeutics, which impair the inflammatory response that generates hypertrophy itself.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomegalyComplement System ProteinsInflammationHumansAnimalsComplement ActivationRenin-Angiotensin System

Stichwörter der Autor:innen

autoimmune diseasescardiac arrhythmiascardiac hypertrophycardiac inflammationcardiac remodelingcardiovascular adversitiescardiovascular diseasescardiovascular eventscomplement anaphylatoxinscomplement immune systemcomplement in metabolic diseasesgenetic defects in complement genesinfectious diseases

Substanzen

Complement System Proteins

Autor:innen und Institutionen

  • Center for Metabolic and Degenerative Diseases, The Brown Foundation Institute of Molecular Medicine for Prevention of Human Diseases, UTHealth-McGovern Medical School, Houston, TX 77030, USA.
  • Center for Human Genetics, The Brown Foundation Institute of Molecular Medicine for Prevention of Human Diseases, UTHealth-McGovern Medical School, Houston, TX 77030, USA.
  • Department of Biochemistry and Molecular Biology, UTHealth-McGovern Medical School, Houston, TX 77030, USA.
  • Department of Cardiology, DeBakey Heart & Vascular Center, Houston Methodist Weill Cornell Medical College, Houston, TX 77030, USA.
  • Division of Rheumatology-Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Anesthesiology, UTHealth-McGovern Medical School, Houston, TX 77030, USA.

ORCID-Profile: Kathryn D Hok, Anthony Shadid, Tingting Weng-Mills, Rajarajan A Thandavarayan, Marcos I Restrepo

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Hok, K. D., Rich, H. E., Shadid, A., Gunamalai, L., Weng-Mills, T., Thandavarayan, R. A., Banda, N. K., Doursout, M. F., Restrepo, M. I., & Shivshankar, P. (2025). Functional Roles of the Complement Immune System in Cardiac Inflammation and Hypertrophy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209931

Vancouver

Hok KD, Rich HE, Shadid A, Gunamalai L, Weng-Mills T, Thandavarayan RA, et al. Functional Roles of the Complement Immune System in Cardiac Inflammation and Hypertrophy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209931

BibTeX
@article{Hok2025,
  author = {Hok, Kathryn D and Rich, Haydn E and Shadid, Anthony and Gunamalai, Lavanya and Weng-Mills, Tingting and Thandavarayan, Rajarajan A and Banda, Nirmal K and Doursout, Marie-Francoise and Restrepo, Marcos I and Shivshankar, Pooja},
  title = {Functional Roles of the Complement Immune System in Cardiac Inflammation and Hypertrophy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26209931}
}
Kostenlos starten →